Regeneron Pharmaceuticals Inc (REGN)
843.60
+5.40
(+0.64%)
USD |
NASDAQ |
Nov 01, 16:00
843.60
0.00 (0.00%)
After-Hours: 20:00
Regeneron Pharmaceuticals Gross Profit Margin (Quarterly): 86.80% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 86.80% |
| June 30, 2024 | 86.46% |
| March 31, 2024 | 86.21% |
| December 31, 2023 | 84.95% |
| September 30, 2023 | 87.02% |
| June 30, 2023 | 87.18% |
| March 31, 2023 | 85.53% |
| December 31, 2022 | 84.17% |
| September 30, 2022 | 89.18% |
| June 30, 2022 | 89.60% |
| March 31, 2022 | 86.34% |
| December 31, 2021 | 80.16% |
| September 30, 2021 | 86.87% |
| June 30, 2021 | 86.50% |
| March 31, 2021 | 87.82% |
| December 31, 2020 | 85.43% |
| September 30, 2020 | 88.06% |
| June 30, 2020 | 85.89% |
| March 31, 2020 | 88.11% |
| December 31, 2019 | 88.10% |
| September 30, 2019 | 87.07% |
| June 30, 2019 | 90.76% |
| March 31, 2019 | 87.46% |
| December 31, 2018 | 72.28% |
| September 30, 2018 | 93.36% |
| Date | Value |
|---|---|
| June 30, 2018 | 94.30% |
| March 31, 2018 | 92.40% |
| December 31, 2017 | 93.32% |
| September 30, 2017 | 93.05% |
| June 30, 2017 | 93.00% |
| March 31, 2017 | 93.62% |
| December 31, 2016 | 93.91% |
| September 30, 2016 | 96.38% |
| June 30, 2016 | 94.31% |
| March 31, 2016 | 90.69% |
| December 31, 2015 | 89.91% |
| September 30, 2015 | 90.41% |
| June 30, 2015 | 91.10% |
| March 31, 2015 | 90.35% |
| December 31, 2014 | 92.59% |
| September 30, 2014 | 92.34% |
| June 30, 2014 | 93.03% |
| March 31, 2014 | 93.04% |
| December 31, 2013 | 92.12% |
| September 30, 2013 | 93.54% |
| June 30, 2013 | 91.34% |
| March 31, 2013 | 93.39% |
| December 31, 2012 | 92.72% |
| September 30, 2012 | 95.29% |
| June 30, 2012 | 92.82% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
80.16%
Minimum
Dec 2021
89.60%
Maximum
Jun 2022
86.52%
Average
86.65%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 61.07% |
| Eli Lilly and Co | 81.02% |
| Pfizer Inc | 70.27% |
| Biogen Inc | 74.10% |
| Vertex Pharmaceuticals Inc | 85.94% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.19% |
| Return on Assets | 13.44% |
| Return on Invested Capital | 16.02% |
| Profit Margin (Quarterly) | 36.03% |
| Operating Margin (Quarterly) | 33.21% |
| Return on Net Operating Assets | 33.97% |